GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

100 hedge funds and large institutions have $64M invested in Sanofi Contingent Value Rights in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

50% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 16

Holders
100
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$612K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$254K
2
+$168K
3
+$48K
4
TSS
Two Sigma Securities
New York
+$11K
5
Goldman Sachs
Goldman Sachs
New York
+$2.72K

Top Sellers

1
-$76K
2
-$56K
3
-$53.5K
4
UOC
UBS O'Connor
Illinois
-$32.7K
5
Citadel Advisors
Citadel Advisors
Florida
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$4K
52
$3K
53
$3K
54
$2.3K
55
$2K
56
$1K
57
$1K
58
$1K
59
$1K
60
$1K
61
$596
62
$429
63
$142
64
$118
65
$55
66
$6
67
–
68
–
69
–
70
–
71
–
1 2
3